Overexpression of p53 and bcl-2 proteins and the presence of HPV infection are independent events in head and neck cancer

Journal of Oral Pathology and Medicine

Volumn 29, Issue 4, 2000, Pages 173-179

  Badaracco, Gianna ^a   Venuti, Aldo ^a   Bartolazzi, Armande ^a   Morello, Roberte ^a   Marzetti, Francesco ^a   Marcante, Maria Luisa ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

bcl 2; Head and neck cancer; Human papillomavirus; p53

Indexed keywords

CANCER SCREENING; HEAD AND NECK CANCER; POLYMERASE CHAIN REACTION; PROTEIN BCL 2; PROTEIN EXPRESSION; PROTEIN P53; STATISTICAL ANALYSIS; TUMOR DIAGNOSIS; TUMOR SUPPRESSOR GENE; VIRUS INFECTION; WART VIRUS;

ADULT; AGED; ALCOHOL DRINKING; ANALYSIS OF VARIANCE; CARCINOMA, SQUAMOUS CELL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS C-BCL-2; RISK FACTORS; SMOKING; TONGUE NEOPLASMS; TONSILLAR NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR VIRUS INFECTIONS;

EID: 0034107950     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0714.2000.290405.x     Document Type: Article

References (33)

1. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Human papillomaviruses: Vol. 64. Lyon: International Agency for Research on Cancer, 1995; IARC Scientific Publications.
2. Steinberg BM, DiLorenzo TP. A possible role for human papillomaviruses in head and neck cancer. Cancer Metast Rev 1996; 15: 91-112.
3. McKaig RG, Baric RS, Olshan AF. Human papillomavirus and head and neck cancer: epidemiology and molecular biology. Head Neck 1998; 20: 250-65.
4. Snijders PJF, Scholes AGM, Hart CA, et al. Prevalence of mucosotropic human papillomaviruses in squamous-cell carcinomas of the head and neck. Int J Cancer 1996; 66: 464-9.
5. Lane DP. Cancer: p53, guardian of the genome. Nature 1992; 358: 15-6.
6. Hollstein M, Sidransky D, Vogelstein B, Harris CC. P53 mutations in human cancers. Science 1991; 253: 49-53.
7. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994; 54: 4855-78.
8. Werness BA, Levine AJ, Howley PM. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 1990; 248: 76-9.
9. Tsujimoto Y, Cossman J, Jaffe E, Croce CM. Involvement of the bcl-2 gene in human follicular lymphoma. Science 1985; 228: 1440-3.
10. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990; 348: 334-6.
11. Reed JC. Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994; 124: 1-6.
12. Ryan JJ, Prochownik E, Gottlieb CA, et al. c-myc and bcl-2 modulate p53 function by altering p53 subcellular trafficking during the cell cycle. Proc Natl Acad Sci USA 1994; 91: 5878-82.
13. McCurrach ME, Connor TM, Knudson CM, Korsmeyer SJ, Lowe SW. Bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis. Proc Natl Acad Sci USA 1997; 94: 2345-9.
14. Korsmeyer SJ. Bcl-2 gene family and the regulation of programmed cell death. Cancer Res 1999; 59: 1693-700.
15. Jordan RCK, Catzavelos GC, Barrett AW, Speight PM. Differential expression of bcl-2 and bax in squamous cell carcinoma of the oral cavity. Eur J Cancer B Oral Oncol 1996; 32: 394-400.
16. Atula S, Kurvinen K, Grenman R, Syrjanen S. SSCP pattern indicative for p53 mutation is related to advanced stage and high-grade of tongue cancer. Eur J Cancer B Oral Oncol 1996; 32: 222-9.
17. Lu QL, Elia G, Lucas S, Thomas JA. Bcl-2 proto-oncogene expression in Epstein-Barr-virus-associated nasopharyngeal carcinoma. Int J Cancer 1993; 53: 29-35.
18. Blot WJ, McLaughlin JK, Winn DM, et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 1988; 48: 3282-7.
19. Balaram P, Nalinakumari KR, Abraham E, et al. Human papillomaviruses in 91 oral cancers from Indian betel quid chewers - high prevalence and multiplicity of infections. Int J Cancer 1995; 61: 450-4.
20. Brennan JA, Boyle JO, Koch WM, et al. Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck. N Engl J Med 1995; 332: 712-7.
21. Pillai MR, Halabi S, McKalip A, et al. The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer. Cancer Epidemiol Biomarkers Prev 1996; 5: 329-35.
22. Kurvinen K, Syrjanen K, Syrjanen S. P53 and bcl-2 proteins as prognostic markers in human papillomavirus-associated cervical lesions. J Clin Oncol 1996; 14: 2120-30.
23. Barten M, Ostwald C, Milde-Langosch K, Muller P, Wukasch Y, Loning T. HPV DNA and p53 alterations in oropharyngeal carcinomas. Virchows Arch 1995; 427: 153-7.
24. Ravi D, Nalinakumari KR, Rajaram RS, Nair MK, Pillai MR. Expression of programmed cell death regulatory p53 and bcl-2 proteins in oral lesions. Cancer Lett 1996; 105: 139-46.
25. Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinsky SM. Use of polymerase chain reaction amplification for the detection of genital human papillomavirus. Cancer Cells 1989; 7: 209-14.
26. Venuti A, Badaracco G, Marcante ML. Detection and typing of human papillomavirus by single hybridization. J Virol Methods 1995; 51: 115-24.
27. Badaracco G, Venuti A, Di Lonardo A, et al. Concurrent HPV infection in oral and genital mucosa. J Oral Pathol Med 1998; 27: 130-4.
28. Snijders P, van den Brule A, Meijer C, Walboomers J. HPV and cancer of the aerodigestive tract. Papillomavirus Report 1995; 6: 157-62.
29. Atula S, Kurvinen K, Grenman R, Syrjanen S. Human papillomavirus and Epstein-Barr virus in epithelial carcinomas of the head and neck region. Anticancer Res 1997; 17: 4427-33.
30. Franceschi S, Muñoz N, Bosch XF, Snijders PJF, Walboomers JMM. Human papillomavirus and cancers of the upper aerodigestive tract. A review of epidemiological and experimental evidence. Cancer Epidemiol Biomarkers Prev 1996; 5: 567-75.
31. Dowell SP, Ogden GR. The use of antigen retrieval for immunohistochemical detection of p53 over-expression in malignant and benign oral mucosa: a cautionary note. J Oral Pathol Med 1996; 25: 60-4.
32. 1 regulation in human head and neck cancer. Cancer Res 1995; 55: 949-56.
33. Reed AL, Califano J, Cairns P, et al. High frequency of p16 (CDKN2/ MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res 1996; 56: 3630-3.